Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions

Thrombosis

Interventions

DRUG

BMS-986141

DRUG

Placebo

DRUG

Aspirin

DRUG

Itraconazole

Trial Locations (2)

Ppd Development, Lp, Austin

West Coast Clinical Trials, Llc, Cypress